查看“Warburg效应”的源代码

<!DOCTYPE html>
<html lang="zh-CN">
<head>
<meta charset="UTF-8">
<style>
    :root {
        --primary-blue: #0056b3; /* SinoCellGene Blue */
        --light-blue-bg: #f0f7ff;
        --border-color: #d1d5db;
        --text-main: #333333;
        --text-secondary: #666666;
    }
    body {
        font-family: "Helvetica Neue", Arial, "PingFang SC", "Microsoft YaHei", sans-serif;
        line-height: 1.6;
        color: var(--text-main);
        max-width: 800px;
        margin: 0 auto;
        padding: 20px;
        background-color: #ffffff;
    }
    
    /* Summary Section */
    .summary-container {
        border-bottom: 2px solid var(--primary-blue);
        padding-bottom: 15px;
        margin-bottom: 25px;
    }
    .summary-title {
        font-size: 2.2em;
        font-weight: bold;
        color: #000;
        margin-bottom: 10px;
    }
    .summary-text {
        font-size: 1.1em;
        color: #2c3e50;
        text-align: justify;
    }

    /* Infobox Styling */
    .infobox {
        width: 320px;
        float: right;
        margin-left: 20px;
        margin-bottom: 20px;
        border: 1px solid #a2a9b1;
        background-color: #f8f9fa;
        font-size: 0.9em;
        box-shadow: 0 2px 5px rgba(0,0,0,0.05);
    }
    .infobox-header {
        background: linear-gradient(180deg, #eef6fc 0%, #cceeff 100%);
        padding: 10px;
        text-align: center;
        font-weight: bold;
        font-size: 1.2em;
        border-bottom: 1px solid #a2a9b1;
        color: #000;
    }
    .infobox-image {
        padding: 15px; /* Image container padding */
        text-align: center;
        background-color: #fff;
        border-bottom: 1px solid #a2a9b1;
    }
    .infobox-image img {
        max-width: 90%; /* Not full width */
        height: auto;
    }
    .infobox-table {
        width: 100%;
        border-collapse: collapse;
    }
    .infobox-table th {
        text-align: left;
        padding: 6px 10px;
        background-color: #eaf3ff; /* Very light blue for labels */
        color: #444;
        width: 40%;
        vertical-align: top;
        font-weight: bold;
        border-bottom: 1px solid #e0e0e0;
    }
    .infobox-table td {
        padding: 6px 10px;
        vertical-align: top;
        border-bottom: 1px solid #e0e0e0;
        line-height: 1.4;
    }
    
    /* Body Modules */
    .module-title {
        font-size: 1.5em;
        border-left: 5px solid var(--primary-blue);
        padding-left: 10px;
        margin-top: 30px;
        margin-bottom: 15px;
        background-color: #f9f9f9;
        padding-top: 5px;
        padding-bottom: 5px;
    }
    
    /* Clinical Table */
    .clinical-table {
        width: 100%;
        border-collapse: collapse;
        margin: 15px 0;
        font-size: 0.95em;
    }
    .clinical-table th {
        background-color: var(--primary-blue);
        color: white;
        padding: 10px;
        text-align: left;
    }
    .clinical-table td {
        border: 1px solid #ddd;
        padding: 10px;
    }
    .clinical-table tr:nth-child(even) {
        background-color: #f2f2f2;
    }

    /* Key Concepts Module */
    .concept-box {
        background-color: #fffbea;
        border: 1px solid #f0e68c;
        padding: 15px;
        border-radius: 4px;
        margin-top: 15px;
    }
    .concept-item {
        margin-bottom: 10px;
    }
    .concept-term {
        font-weight: bold;
        color: #d35400;
    }

    /* References */
    .references {
        font-size: 0.85em;
        color: #555;
        margin-top: 40px;
        border-top: 1px solid #eee;
        padding-top: 20px;
    }
    .references li {
        margin-bottom: 8px;
    }

    /* Knowledge Graph Nav */
    .bottom-nav {
        margin-top: 30px;
        padding: 15px;
        background-color: #f8f9fa;
        border-top: 2px solid var(--primary-blue);
        display: flex;
        justify-content: space-around;
        font-size: 0.9em;
    }
    .nav-item {
        color: var(--primary-blue);
        text-decoration: none;
        font-weight: bold;
    }
    .nav-item:hover {
        text-decoration: underline;
    }
</style>
</head>
<body>

<div class="summary-container">
    <div class="summary-title">Warburg Effect (瓦尔堡效应)</div>
    <div class="summary-text">
        <strong>瓦尔堡效应 (Warburg Effect)</strong>，又称<strong>有氧糖酵解 (Aerobic Glycolysis)</strong>，是肿瘤细胞代谢重编程的最典型特征。即便在氧气充足的条件下，肿瘤细胞也倾向于通过糖酵解途径将葡萄糖转化为乳酸，而非进入线粒体进行氧化磷酸化。这一代谢模式虽然在ATP产能效率上较低，但能为肿瘤细胞的快速增殖提供大量的生物合成前体（如核苷酸、氨基酸和脂质），并协助维持氧化还原稳态。
    </div>
</div>

<div class="infobox">
    <div class="infobox-header">Warburg Effect</div>
    <div class="infobox-image">
         
         <div style="font-size:0.8em; color:#666; margin-top:5px;">有氧糖酵解代谢示意图</div>
    </div>
    <table class="infobox-table">
        <tr>
            <th>中文名</th>
            <td>瓦尔堡效应</td>
        </tr>
        <tr>
            <th>别名</th>
            <td>有氧糖酵解 (Aerobic Glycolysis)</td>
        </tr>
        <tr>
            <th>发现者</th>
            <td>Otto Warburg</td>
        </tr>
        <tr>
            <th>发现年份</th>
            <td>~1924年</td>
        </tr>
        <tr>
            <th>核心特征</th>
            <td>高葡萄糖摄取、高乳酸生成</td>
        </tr>
        <tr>
            <th>关键酶</th>
            <td>HK2, PKM2, LDHA, GLUT1</td>
        </tr>
        <tr>
            <th>关键转录因子</th>
            <td>HIF-1α, c-MYC</td>
        </tr>
        <tr>
            <th>诊断应用</th>
            <td><sup>18</sup>F-FDG PET/CT</td>
        </tr>
        <tr>
            <th>ICD-11相关</th>
            <td>肿瘤代谢异常</td>
        </tr>
    </table>
</div>

<h3 class="module-title">分子机制 (Molecular Mechanism)</h3>
<p>瓦尔堡效应并非线粒体功能缺陷的结果，而是主动的代谢适应。其核心调控机制包括：</p>
<ul>
    <li><strong>关键酶的异构体转换：</strong> 肿瘤细胞高表达己糖激酶2 (<strong>HK2</strong>) 和丙酮酸激酶M2型 (<strong>PKM2</strong>)。PKM2作为低活性的二聚体存在，导致糖酵解中间产物堆积，分流进入戊糖磷酸途径 (PPP) 和丝氨酸合成途径。</li>
    <li><strong>转录调控：</strong> <strong>HIF-1α</strong> (缺氧诱导因子) 上调葡萄糖转运蛋白 (<strong>GLUT1</strong>) 和乳酸脱氢酶A (<strong>LDHA</strong>) 的表达，促进丙酮酸转化为乳酸，同时抑制丙酮酸进入线粒体。<strong>c-MYC</strong> 则协同促进谷氨酰胺代谢和糖酵解酶的转录。</li>
    <li><strong>肿瘤微环境：</strong> 生成的大量乳酸被分泌到细胞外，酸化肿瘤微环境，抑制效应T细胞功能，促进免疫逃逸和肿瘤转移。</li>
</ul>

<h3 class="module-title">临床意义与应用 (Clinical Relevance)</h3>
<table class="clinical-table">
    <thead>
        <tr>
            <th>应用领域</th>
            <th>机制基础</th>
            <th>临床实践</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td><strong>影像诊断</strong></td>
            <td>肿瘤细胞对葡萄糖的摄取率远高于正常组织 (GLUT1高表达)</td>
            <td><strong><sup>18</sup>F-FDG PET/CT</strong> 扫描是目前利用瓦尔堡效应检测肿瘤分期和转移的金标准。</td>
        </tr>
        <tr>
            <td><strong>预后评估</strong></td>
            <td>高乳酸水平与肿瘤侵袭性、放化疗抵抗相关</td>
            <td>LDHA 或 MCT1/4 高表达常提示预后不良 (Poor Prognosis)。</td>
        </tr>
        <tr>
            <td><strong>治疗抵抗</strong></td>
            <td>ATP快速生成及抗凋亡能力</td>
            <td>瓦尔堡效应有助于肿瘤细胞抵抗缺氧环境，降低放疗敏感性。</td>
        </tr>
    </tbody>
</table>

<h3 class="module-title">靶向治疗策略 (Therapeutic Strategies)</h3>
<p>针对瓦尔堡效应的药物开发主要集中在阻断糖酵解的关键限速步骤：</p>
<ul>
    <li><strong>己糖激酶抑制剂：</strong> 如 <strong>2-Deoxy-D-glucose (2-DG)</strong> 和 <strong>Lonidamine</strong>，旨在竞争性抑制HK2，阻断葡萄糖利用的第一步。</li>
    <li><strong>PKM2 激活剂：</strong> 试图将低活性的PKM2二聚体转化为高活性的四聚体，迫使代谢流进入线粒体，减少合成代谢前体的积累。</li>
    <li><strong>乳酸转运抑制剂：</strong> 靶向 <strong>MCT1/MCT4</strong> (如 AZD3965)，阻断乳酸外排，导致肿瘤细胞内酸中毒死亡。</li>
    <li><strong>饮食干预：</strong> 生酮饮食 (Ketogenic Diet) 旨在限制血糖供应，利用正常细胞能利用酮体而部分肿瘤细胞不能的差异。</li>
</ul>

<h3 class="module-title">关键相关概念 (Key Related Concepts)</h3>
<div class="concept-box">
    <div class="concept-item">
        <span class="concept-term">逆瓦尔堡效应 (Reverse Warburg Effect):</span> 肿瘤间质细胞 (如成纤维细胞) 进行有氧糖酵解产生乳酸，分泌后被邻近的肿瘤细胞摄取，作为线粒体氧化磷酸化的燃料。
    </div>
    <div class="concept-item">
        <span class="concept-term">巴斯德效应 (Pasteur Effect):</span> 正常细胞中，氧气的存在会抑制糖酵解；而在肿瘤细胞中，这一效应减弱或消失 (即瓦尔堡效应)。
    </div>
    <div class="concept-item">
        <span class="concept-term">谷氨酰胺成瘾 (Glutamine Addiction):</span> 为以此补充因TCA循环受阻而缺失的碳源，许多肿瘤细胞高度依赖谷氨酰胺分解。
    </div>
</div>

<div class="references">
    <h3>参考文献 (References)</h3>
    <ol>
        <li><strong>[Academic Review]</strong> Hanahan, D. (2022). Hallmarks of Cancer: New Dimensions. <em>Cancer Discovery</em>, 12(1), 31-46.</li>
        <li><strong>[Classic Discovery]</strong> Warburg, O., Posener, K., & Negelein, E. (1924). Über den Stoffwechsel der Carcinomzelle. <em>Die Naturwissenschaften</em>.</li>
        <li><strong>[Mechanism]</strong> Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011). Otto Warburg's contributions to current concepts of cancer metabolism. <em>Nature Reviews Cancer</em>, 11(5), 325-337.</li>
        <li><strong>[Recent Update]</strong> Nath, S., & Balling, R. (2024). The Warburg Effect Reinterpreted 100 yr on: A First-Principles Stoichiometric Analysis and Interpretation from the Perspective of ATP Metabolism in Cancer Cells. <em>Function</em>, 5(3), zqae008.</li>
        <li><strong>[Clinical Target]</strong> Vaupel, P., & Multhoff, G. (2021). Revisiting the Warburg effect: historical dogma versus current understanding. <em>The Journal of Physiology</em>, 599(6), 1745-1757.</li>
    </ol>
</div>

<div class="bottom-nav">
    <a href="#" class="nav-item">◀ PKM2</a>
    <a href="#" class="nav-item">▲ 肿瘤代谢重编程</a>
    <a href="#" class="nav-item">HIF-1 Signaling ▶</a>
</div>

</body>
</html>